Deal Watch: Lilly Continues Hectic Deal Stretch Via Renal-Focused Ascidian Collab Scrip Pharma Intelligence 21:49 Fri, 05 Jun
Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership Pharmaceutical Technology 11:57 Thu, 04 Jun
Lilly enters $1.9B kidney disease deal for Ascidian’s exon editors BioWorld 20:04 Wed, 03 Jun Article paywall
Lilly gains license for Ascidian's gene-editing tech to develop kidney disease drugs Rock Hill Herald 12:21 Wed, 03 Jun Article paywall
Ascidian and Lilly Enter Global Research Collaboration to Develop RNA Exon Editors for Devastating Kidney Diseases PR Newswire (Press Release) 12:06 Wed, 03 Jun
Insight into Unique Anatomical Structures of Ascidian Species Ruhr University Bochum 07:47 Wed, 27 May
